StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.78−0.48 (-1.22%)

Close on Nov 17, 2026Market cap $3.76BP/E –Yield –

Xenon Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Xenon Pharmaceuticals's price to book ratio was 3.3× on Nov 11, 2026, against 6.2× a year earlier. Over the last 5 years it ranged from 2.6× to 8.0×, with a median of 3.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.3×−2.9
2025Dec 31, 20256.2×+2.5
2024Dec 31, 20243.7×−1.0
2023Dec 29, 20234.7×+1.4
2022Dec 30, 20223.3×−1.9
2021Dec 31, 20215.2×+2.2
2020Dec 31, 20203.0×−1.6
2019Dec 31, 20194.5×+3.1
2018Dec 31, 20181.4×+0.3
2017Dec 29, 20171.2×−0.8
2016Dec 30, 20162.0×+0.2
2015Dec 31, 20151.8×–

More Xenon Pharmaceuticals figures

See a number that looks wrong?